Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
11Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
ALX Oncology Holdings Inc. (ALXO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
16Total relationships
2Distinct source URLs
5High confidence
0.746Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
ALX Oncology Holdings Inc. Suppliers
Ticker
Name
Confidence
Evidence
PHARMACEUTICAL-CONTRACT-MANUFACTURERS-AND-SUPPLI
PHARMACEUTICAL-CONTRACT-MANUFACTURERS-AND-SUPPLI
92%
The Company has commitments with two other pharmaceutical contract manufacturers and suppliers, including certain future purchase obligations of approximately $ 1.7 million
ALX Oncology Holdings Inc. Customers
Ticker
Name
Confidence
Evidence
FCNCB
First Citizens BancShares, Inc.
72%
from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
FCNCB
First Citizens BancShares, Inc.
72%
Reciprocal relationship from FCNCB graph: Reciprocal relationship from ALXO graph: from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Inter…
ns and Other Commitments The Company has other contractual obligations and other commitments from manufacturing and service contracts, which are presented as follows as of March 31, 2026 (in thousand…
Reciprocal relationship from JAZZ graph: Reciprocal relationship from ALXO graph: Reciprocal relationship from JAZZ graph: Reciprocal relationship from ALXO graph: Reciprocal relationship from JAZZ g…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ALXO graph: ted by movements in our stock price that are beyond our control and therefore any declining value in our equity gran…
SNYNF
Sanofi
72%
ted by movements in our stock price that are beyond our control and therefore any declining value in our equity grants could negatively impact our ability to successfully retain existing employees or…
KBI-BIOPHARMA-INC
KBI-BIOPHARMA-INC
62%
. The Company may terminate this ATM program at any time, pursuant to its terms. Pre-Funded Warrants In October 2023, the Company completed a registered offering (the October 2023 Offering) pursuant …
OXFORD-FINANCE-LLC
OXFORD-FINANCE-LLC
62%
from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
SVB-FIRST-CITIZENS-BANCSHARES-INC
SVB-FIRST-CITIZENS-BANCSHARES-INC
62%
from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
TALLAC-THERAPEUTICS-INC
TALLAC-THERAPEUTICS-INC
62%
. The Company may terminate this ATM program at any time, pursuant to its terms. Pre-Funded Warrants In October 2023, the Company completed a registered offering (the October 2023 Offering) pursuant …
UBS-SECURITIES-LLC
UBS-SECURITIES-LLC
62%
from the reduction in workforce, and a decrease of $0.7 million in other G&A costs from corporate legal costs. Interest Income Interest income decreased by $0.3 million for the three months ended Mar…
ALX Oncology Holdings Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ALXO-DEBT-7708
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
ALXO-DEBT
Debt stack $9.7M
90%
Market cache reports total debt of $9.7M.
ALXO-DEBT-7707
Warrants outstanding: 61292
90%
xbrl warrant detail from xbrl 2026-03-31.
ALX Oncology Holdings Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for ALX Oncology Holdings Inc..
ALX Oncology Holdings Inc. Ownership
Holder
Name
Confidence
Evidence
ALXO-OWNER-RA-CAPITAL-MANAGEMENT-L-P
RA CAPITAL MANAGEMENT, L.P.
90%
13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 72 tracked holders.
ALX Oncology Holdings Inc. Extended Supply Chain Network
